JOHN CADRAIN: Open Payments
NPI 1437133006 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 15 payments from 10 companies in 2025. Trend: 2023 $235 · 2024 $252 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 5 | $119 |
| MML US, Inc. | 1 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Abbott Laboratories | 1 | $38 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $32 |
| Valinor Pharma, LLC | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Tonix Medicines, Inc. | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $14 |
Products named: INTELLIS ADAPTIVESTIM, ReActiv8, SYNCHROMEDII, RELISTOR, PROCLAIM, JOURNAVX, MOVANTIK, Belbuca.
Industry payments across TX — which companies pay providers there.
